We highlight features associated with bacteriophage therapy that make it an attractive treatment option for multidrug-resistant infections and also discuss some of the challenges that need to be considered in the design and execution of clinical trials directed at evaluating the efficacy of bacteriophage therapy in humans.
Keywords: antimicrobial resistance (AMR); bacteriophage therapy; multidrug resistance (MDR); phage therapy.
Copyright © 2019 American Society for Microbiology.